Structure | Compound Name | Standard Type | Standard Values (in nM) |
|---|---|---|---|
| Silmitasertib | IC50 | 41.0 [1] | |
| 9H-Purine-2,6-diamine, N2-(2-aminocyclohexyl)-N6-(3-chlorophenyl)-9-ethyl-, cis- | IC50 | 1000.0 [1] | |
| Cdk1/2 Inhibitor III | IC50 | 29.2 [1] | |
| 6-(1,3-Benzodioxol-5-yl)-N-(thiophen-2-ylmethyl)-4-quinazolinamine | IC50 | 6936.0 [1] | |
| CID 46926514 | IC50 | 10000.0 [1] | |
MLA | "Quest Database™ Dual specificity protein kinase CLK3 Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 28 Feb. 2026, https://www.aatbio.com/data-sets/dual-specificity-protein-kinase-clk3-inhibitors-ic50-ki. | |
APA | AAT Bioquest, Inc. (2026, February 28). Quest Database™ Dual specificity protein kinase CLK3 Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/dual-specificity-protein-kinase-clk3-inhibitors-ic50-ki. | |
| BibTeX | EndNote | RefMan |